Camrelizumab plus apatinib for immunochemotherapy-treated advanced esophageal squamous cell carcinoma: Preliminary results of cohort 2 in CAP 02 study.
JOURNAL OF CLINICAL ONCOLOGY(2023)
关键词
carcinoma,apatinib,immunochemotherapy-treated
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要